BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31634914)

  • 1. Life-Gained-Based Versus Risk-Based Selection of Smokers for Lung Cancer Screening.
    Cheung LC; Berg CD; Castle PE; Katki HA; Chaturvedi AK
    Ann Intern Med; 2019 Nov; 171(9):623-632. PubMed ID: 31634914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
    de Koning HJ; Meza R; Plevritis SK; ten Haaf K; Munshi VN; Jeon J; Erdogan SA; Kong CY; Han SS; van Rosmalen J; Choi SE; Pinsky PF; Berrington de Gonzalez A; Berg CD; Black WC; Tammemägi MC; Hazelton WD; Feuer EJ; McMahon PM
    Ann Intern Med; 2014 Mar; 160(5):311-20. PubMed ID: 24379002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
    Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
    JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
    Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
    PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis.
    Toumazis I; Cao P; de Nijs K; Bastani M; Munshi V; Hemmati M; Ten Haaf K; Jeon J; Tammemägi M; Gazelle GS; Feuer EJ; Kong CY; Meza R; de Koning HJ; Plevritis SK; Han SS
    Ann Intern Med; 2023 Mar; 176(3):320-332. PubMed ID: 36745885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive: A Microsimulation Study.
    Caverly TJ; Cao P; Hayward RA; Meza R
    Ann Intern Med; 2018 Jul; 169(1):1-9. PubMed ID: 29809244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute lung cancer risk increases among individuals with >15 quit-years: Analyses to inform the update of the American Cancer Society lung cancer screening guidelines.
    Landy R; Cheung LC; Young CD; Chaturvedi AK; Katki HA
    Cancer; 2024 Jan; 130(2):201-215. PubMed ID: 37909885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of lung cancer risk model (PLCO
    Lebrett MB; Balata H; Evison M; Colligan D; Duerden R; Elton P; Greaves M; Howells J; Irion K; Karunaratne D; Lyons J; Mellor S; Myerscough A; Newton T; Sharman A; Smith E; Taylor B; Taylor S; Walsham A; Whittaker J; Barber PV; Tonge J; Robbins HA; Booton R; Crosbie PAJ
    Thorax; 2020 Aug; 75(8):661-668. PubMed ID: 32631933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea.
    Chen Y; Watson TR; Criss SD; Eckel A; Palazzo L; Sheehan DF; Kong CY
    PLoS One; 2019; 14(7):e0220610. PubMed ID: 31361789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
    Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
    PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The performance of NLST screening criteria in Asian lung cancer patients.
    Kumar V; Becker K; Zheng HX; Huang Y; Xu Y
    BMC Cancer; 2015 Nov; 15():916. PubMed ID: 26582178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk.
    Crosbie PA; Gabe R; Simmonds I; Kennedy M; Rogerson S; Ahmed N; Baldwin DR; Booton R; Cochrane A; Darby M; Franks K; Hinde S; Janes SM; Macleod U; Messenger M; Moller H; Murray RL; Neal RD; Quaife SL; Sculpher M; Tharmanathan P; Torgerson D; Callister ME
    BMJ Open; 2020 Sep; 10(9):e037075. PubMed ID: 32912947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the impact of increasing lung screening eligibility by relaxing the maximum years-since-quit threshold: A simulation modeling study.
    Meza R; Cao P; de Nijs K; Jeon J; Smith RA; Ten Haaf K; de Koning H
    Cancer; 2024 Jan; 130(2):244-255. PubMed ID: 37909874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary Implications of U.S. Preventive Services Task Force and Risk-Based Guidelines for Lung Cancer Screening Eligibility in the United States.
    Landy R; Cheung LC; Berg CD; Chaturvedi AK; Robbins HA; Katki HA
    Ann Intern Med; 2019 Sep; 171(5):384-386. PubMed ID: 31158854
    [No Abstract]   [Full Text] [Related]  

  • 15. Geographic variation in radiologist capacity and widespread implementation of lung cancer CT screening.
    Smieliauskas F; MacMahon H; Salgia R; Shih YC
    J Med Screen; 2014 Dec; 21(4):207-15. PubMed ID: 25118160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the Cohort of Norway: A Population-Based Prospective Study.
    Nguyen OTD; Fotopoulos I; Markaki M; Tsamardinos I; Lagani V; Røe OD
    JTO Clin Res Rep; 2024 Apr; 5(4):100660. PubMed ID: 38586302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period.
    McMahon PM; Kong CY; Weinstein MC; Tramontano AC; Cipriano LE; Johnson BE; Weeks JC; Gazelle GS
    Cancer; 2008 Dec; 113(12):3440-9. PubMed ID: 18988293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "To know or not to know…?" Push and pull in ever smokers lung screening uptake decision-making intentions.
    Tonge JE; Atack M; Crosbie PA; Barber PV; Booton R; Colligan D
    Health Expect; 2019 Apr; 22(2):162-172. PubMed ID: 30289583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invitation strategies and participation in a community-based lung cancer screening programme located in areas of high socioeconomic deprivation.
    Goodley P; Balata H; Alonso A; Brockelsby C; Conroy M; Cooper-Moss N; Craig C; Evison M; Hewitt K; Higgins C; Johnson W; Lyons J; Merchant Z; Rowlands A; Sharman A; Sinnott N; Sperrin M; Booton R; Crosbie PAJ
    Thorax; 2023 Dec; 79(1):58-67. PubMed ID: 37586744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT Lung Screening in Patients with Laryngeal Cancer.
    Piersiala K; Akst LM; Hillel AT; Best SR
    Sci Rep; 2020 Mar; 10(1):4676. PubMed ID: 32170175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.